Oskar Ragnarsson

Summary

Affiliation: Sahlgrenska University Hospital
Country: Sweden

Publications

  1. doi request reprint Clinical features of GH deficiency and effects of 3 years of GH replacement in adults with controlled Cushing's disease
    Charlotte Hoybye
    Department of Endocrinology, Karolinska University Hospital, Solna, SE 171 76 Stockholm, Sweden
    Eur J Endocrinol 162:677-84. 2010
  2. doi request reprint The relationship between glucocorticoid replacement and quality of life in 2737 hypopituitary patients
    Oskar Ragnarsson
    Department of EndocrinologyDiabetes and Metabolism, Sahlgrenska University Hospital and Sahlgrenska Academy, University of Gothenburg, Grona Straket 8, SE 413 45 Gothenburg, SwedenPfizer Endocrine CareSollentuna, SwedenWilliam Harvey Research InstituteCentre for Clinical Endocrinology, St Bartholomew s Hospital, Queen Mary, University of London, London, UKDepartment of Women s and Children s HealthUppsala University, Uppsala, Sweden
    Eur J Endocrinol 171:571-9. 2014
  3. doi request reprint Body composition and bone mineral density in women with Cushing's syndrome in remission and the association with common genetic variants influencing glucocorticoid sensitivity
    Oskar Ragnarsson
    Institute of Medicine at Sahlgrenska AcademyUniversity of Gothenburg, Goteborg, SwedenDepartment of EndocrinologySkaraborg Hospital, Skovde, SwedenDepartment of Internal MedicineNorra Älvsborgs Hospital, Trollhattan, SwedenDepartment of Internal MedicineSödra Älvsborgs Hospital, Boras, SwedenDepartment of SurgerySahlgrenska University Hospital, Sahlgrenska Academy, University of Gothenburg, Goteborg, Sweden
    Eur J Endocrinol 172:1-10. 2015
  4. doi request reprint Effect of short-term GH and testosterone administration on body composition and glucose homoeostasis in men receiving chronic glucocorticoid therapy
    Oskar Ragnarsson
    Department of Endocrinology, Sahlgrenska University Hospital and Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Grona Straket 8, SE 413 45 Goteborg, Sweden
    Eur J Endocrinol 168:243-51. 2013
  5. doi request reprint Neurodegenerative and inflammatory biomarkers in cerebrospinal fluid in patients with Cushing's syndrome in remission
    Oskar Ragnarsson
    Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Goteborg, Sweden
    Eur J Endocrinol 169:211-5. 2013
  6. doi request reprint Long-term cognitive impairments and attentional deficits in patients with Cushing's disease and cortisol-producing adrenal adenoma in remission
    Oskar Ragnarsson
    Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, SE 413 45 Goteborg, Sweden
    J Clin Endocrinol Metab 97:E1640-8. 2012
  7. doi request reprint Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood
    Oskar Ragnarsson
    Department of Endocrinology, Sahlgrenska University Hospital and University of Gothenburg, Grona Straket 8, Gothenburg, Sweden
    Eur J Endocrinol 166:593-600. 2012
  8. doi request reprint Glucocorticoid replacement therapy is independently associated with reduced bone mineral density in women with hypopituitarism
    Oskar Ragnarsson
    Department of Endocrinology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Goteborg, Sweden
    Clin Endocrinol (Oxf) 76:246-52. 2012
  9. doi request reprint The impact of glucocorticoid replacement on bone mineral density in patients with hypopituitarism before and after 2 years of growth hormone replacement therapy
    Hjalmar Ragnar Agnarsson
    Faculty of Medicine H R A, University of Iceland, 101 Reykjavik Iceland and Institute of Medicine G J, O R, Sahlgrenska Academy, University of Gothenburg, SE 413 45 Göteborg Sweden
    J Clin Endocrinol Metab 99:1479-85. 2014
  10. doi request reprint Discontinuing long-term GH replacement therapy--a randomized, placebo-controlled crossover trial in adult GH deficiency
    Helena Filipsson Nyström
    Department of Endocrinology, Sahlgrenska University Hospital, and Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, SE 41345 Goteborg, Sweden
    J Clin Endocrinol Metab 97:3185-95. 2012

Collaborators

Detail Information

Publications15

  1. doi request reprint Clinical features of GH deficiency and effects of 3 years of GH replacement in adults with controlled Cushing's disease
    Charlotte Hoybye
    Department of Endocrinology, Karolinska University Hospital, Solna, SE 171 76 Stockholm, Sweden
    Eur J Endocrinol 162:677-84. 2010
    ..In this study, we evaluated the features of GHD in a large cohort of controlled CD patients, and assessed the effect of GH treatment...
  2. doi request reprint The relationship between glucocorticoid replacement and quality of life in 2737 hypopituitary patients
    Oskar Ragnarsson
    Department of EndocrinologyDiabetes and Metabolism, Sahlgrenska University Hospital and Sahlgrenska Academy, University of Gothenburg, Grona Straket 8, SE 413 45 Gothenburg, SwedenPfizer Endocrine CareSollentuna, SwedenWilliam Harvey Research InstituteCentre for Clinical Endocrinology, St Bartholomew s Hospital, Queen Mary, University of London, London, UKDepartment of Women s and Children s HealthUppsala University, Uppsala, Sweden
    Eur J Endocrinol 171:571-9. 2014
    ..The aim of this study was to analyse the impact of glucocorticoid (GC) replacement on QoL. The main hypothesis was that ACTH-insufficient patients experience a dose-dependent deterioration in QoL...
  3. doi request reprint Body composition and bone mineral density in women with Cushing's syndrome in remission and the association with common genetic variants influencing glucocorticoid sensitivity
    Oskar Ragnarsson
    Institute of Medicine at Sahlgrenska AcademyUniversity of Gothenburg, Goteborg, SwedenDepartment of EndocrinologySkaraborg Hospital, Skovde, SwedenDepartment of Internal MedicineNorra Älvsborgs Hospital, Trollhattan, SwedenDepartment of Internal MedicineSödra Älvsborgs Hospital, Boras, SwedenDepartment of SurgerySahlgrenska University Hospital, Sahlgrenska Academy, University of Gothenburg, Goteborg, Sweden
    Eur J Endocrinol 172:1-10. 2015
    ..The aim of this study was to evaluate body composition and BMD in women with CS in long-term remission and the influence of polymorphisms in genes affecting glucocorticoid (GC) sensitivity on these end-points...
  4. doi request reprint Effect of short-term GH and testosterone administration on body composition and glucose homoeostasis in men receiving chronic glucocorticoid therapy
    Oskar Ragnarsson
    Department of Endocrinology, Sahlgrenska University Hospital and Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Grona Straket 8, SE 413 45 Goteborg, Sweden
    Eur J Endocrinol 168:243-51. 2013
    ..The objective of this study was to investigate whether short-term treatment with GH and testosterone (T) can increase lean mass without major impairment of glucose homoeostasis in patients on GC therapy...
  5. doi request reprint Neurodegenerative and inflammatory biomarkers in cerebrospinal fluid in patients with Cushing's syndrome in remission
    Oskar Ragnarsson
    Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Goteborg, Sweden
    Eur J Endocrinol 169:211-5. 2013
    ..The aim of this study was to analyze neurodegenerative and inflammatory biomarkers in the CSF of patients with CS in remission...
  6. doi request reprint Long-term cognitive impairments and attentional deficits in patients with Cushing's disease and cortisol-producing adrenal adenoma in remission
    Oskar Ragnarsson
    Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, SE 413 45 Goteborg, Sweden
    J Clin Endocrinol Metab 97:E1640-8. 2012
    ..Cognitive function is impaired in patients with active Cushing's syndrome (CS)...
  7. doi request reprint Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood
    Oskar Ragnarsson
    Department of Endocrinology, Sahlgrenska University Hospital and University of Gothenburg, Grona Straket 8, Gothenburg, Sweden
    Eur J Endocrinol 166:593-600. 2012
    ..Cushing's disease (CD) and non-functioning pituitary adenoma (NFPA) are rare in paediatric patients. The aim of this study was to describe long-term consequences in adults with GH deficiency (GHD) treated for CD or NFPA during childhood...
  8. doi request reprint Glucocorticoid replacement therapy is independently associated with reduced bone mineral density in women with hypopituitarism
    Oskar Ragnarsson
    Department of Endocrinology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Goteborg, Sweden
    Clin Endocrinol (Oxf) 76:246-52. 2012
    ..The objective of this study was to analyse the effects of glucocorticoid (GC) replacement on cardiovascular risk factors and BMD in patients with hypopituitarism...
  9. doi request reprint The impact of glucocorticoid replacement on bone mineral density in patients with hypopituitarism before and after 2 years of growth hormone replacement therapy
    Hjalmar Ragnar Agnarsson
    Faculty of Medicine H R A, University of Iceland, 101 Reykjavik Iceland and Institute of Medicine G J, O R, Sahlgrenska Academy, University of Gothenburg, SE 413 45 Göteborg Sweden
    J Clin Endocrinol Metab 99:1479-85. 2014
    ..Patients with hypopituitarism have reduced bone mineral density (BMD) and increased fracture risk...
  10. doi request reprint Discontinuing long-term GH replacement therapy--a randomized, placebo-controlled crossover trial in adult GH deficiency
    Helena Filipsson Nyström
    Department of Endocrinology, Sahlgrenska University Hospital, and Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, SE 41345 Goteborg, Sweden
    J Clin Endocrinol Metab 97:3185-95. 2012
    ..Adult GH deficiency (GHD) is associated with impaired quality of life (QoL) and increased cardiovascular risk. Continued long-term efficacy in terms of QoL and cardiovascular risk factors has been indicated in open surveillance studies...
  11. doi request reprint Common genetic variants in the glucocorticoid receptor and the 11β-hydroxysteroid dehydrogenase type 1 genes influence long-term cognitive impairments in patients with Cushing's syndrome in remission
    Oskar Ragnarsson
    Institute of Medicine O R, C A M G, R B, G J, Institute of Neuroscience and Physiology P B, and Vigilance and Neurocognition Laboratory D N E, Sahlgrenska Academy, University of Gothenburg, SE 413 45 Göteborg Sweden
    J Clin Endocrinol Metab 99:E1803-7. 2014
    ..Cognitive function is impaired in patients with Cushing's syndrome (CS) in remission...
  12. doi request reprint Cushing's syndrome: a structured short- and long-term management plan for patients in remission
    Oskar Ragnarsson
    Institute of Medicine, Sahlgrenska Academy, University of Gothenburg and Department of Endocrinology, Sahlgrenska University Hospital, Grona Straket 8, SE 413 45 Gothenburg, Sweden
    Eur J Endocrinol 169:R139-52. 2013
    ..The focus of the long-term specialised care should be to identify cognitive impairments and psychiatric disorders, evaluate cardiovascular risk, follow pituitary function and detect possible recurrence of CS...
  13. doi request reprint Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide
    Daniel Bengtsson
    Department of Endocrinology D B, P B, Skane University Hospital, SE 205 02 Malmo, Sweden Department of Pathology H D S, and Department of Endocrinology M A, Odense University Hospital, University of Southern Denmark 5000 Odense, Denmark Department of Endocrinology and Nutrition D M, Cliniques Universitaires St Luc, Universite Catholique de Louvain, 1200 Brussels, Belgium Department of Endocrinology, Metabolism and Diabetology K B, C H, M P, Karolinska University Hospital, SE 141 86 Stockholm, Sweden Department of Medical Endocrinology and Metabolism U F R, A K R, Rigshospitalet, Copenhagen University Hospital, DK 2100 Copenhagen, Denmark Department of Medicine, Division of Endocrinology A J v d L, Erasmus University MC, 3000 CA Rotterdam, The Netherlands and Department of Endocrinology G J, O R, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, SE 413 45 Gothenburg, Sweden
    J Clin Endocrinol Metab 100:1689-98. 2015
    ..Temozolomide (TMZ) is an oral alkylating drug with good tolerability, approved for treatment of malignant gliomas. The experience of its use in pituitary tumors is limited...
  14. doi request reprint The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011
    Axel Tjörnstrand
    Sahlgrenska AcademyDepartment of OncologyInstitute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenDepartment of EndocrinologySahlgrenska University Hospital, Gothenburg, Sweden
    Eur J Endocrinol 171:519-26. 2014
    ..The number of studies on the incidence of pituitary adenomas (PAs) is limited. The aim of this study was to evaluate the standardised incidence rate (SIR) of PAs in western Sweden...
  15. doi request reprint Cardiovascular and metabolic impact of glucocorticoid replacement therapy
    Gudmundur Johannsson
    Department of Endocrinology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Front Horm Res 43:33-44. 2014
    ..Studies that have compared various regimens for replacement therapy will be addressed and recent developments that may improve outcome in patients with AI will be discussed...